Behavioral and Pharmacological Analysis of Drugs of Abuse

滥用药物的行为和药理学分析

基本信息

项目摘要

6. Project Summary/Abstract Hallucinogens of all types are subject to widespread abuse especially by adolescents and young adults in this country. Perhaps equally important is the possibility that these drugs may offer clues to the etiology of the most serious forms of mental illness. The long-term objectives of the present proposal are to characterize hallucinogens behaviorally and pharmacologically with the ultimate goal of establishing their mechanisms of action. Although they are united by a common term, hallucinogen, these drugs represent distinct pharmacological entities. Lysergic acid diethylamide [LSD] is chemically and pharmacologically quite different from the simpler indoleamines represented by DMT and psilocybin. Indeed, in terms of a presumed receptor mechanism of hallucinogenic action, LSD more closely resembles a phenethylamine such as mescaline. Nonetheless, all of these drugs are joined by prominent activity via serotonergic [5- hydroxytryptaminergic] mechanisms. Until recently, the same could not be said for phencyclidine [PCP, Angel Dust]. However, a unifying serotonergic-glutamatergic mechanism is beginning to emerge with the hypothesis that glutamate release may represent a final common pathway for hallucinogens. Nonetheless, to say that all of these drugs are somehow serotonergic in nature obscures the fact that 14 distinct serotonergic receptors are known, each with a distinct neuroanatomic distribution and array of functions. The decision to focus in the present proposal on, 5-HT2c, 5-HT7, 5-HT2~a,n d 5-HTqAr eceptors is based upon suggestive pharmacological and behavioral evidence, which links these receptors to hallucinogenesis. The primary behavioral index will continue to be the stimulus effects of hallucinogens in rodents, effects widely believed to have significant subjective correlates in humans. In addition, hallucinogens will be characterized using in vivo microdialysis to correlate glutamate release with behavioral activity. It is expected that integration of the resulting data will provide new understanding of the mode of action of hallucinogens, especially those subject to abuse. In addition, these studies may contribute to our understanding of the most serious forms of mental illness including anxiety, depression, and psychosis. Finally, the role of the internet in expanding interest in these and other club drugs such as MDMA [Ecstasy] especially among youthful segments of society is inestimable but will almost certainly lead to increased illicit use. This likelihood coupled with continued interest in the therapeutic use of agents such as psilocybin makes a detailed pharmacological assessment of these drugs of utmost importance.
6.项目总结/摘要 所有类型的致幻剂都受到广泛的滥用,特别是青少年, 这个国家的年轻人。也许同样重要的是,这些药物可能 为最严重的精神疾病的病因学提供了线索。远景目标 目前的建议是描述致幻剂的行为和 最终目标是建立他们的行动机制。虽然他们是由一个 这两种药物的共同术语是致幻剂,它们代表不同的药理学实体。麦角 酸二乙基酰胺[LSD]在化学上和物理上与更简单的 以DMT和裸盖菇素为代表的吲哚胺。事实上,就一种假定的受体而言, 致幻剂的作用机制,LSD更类似于苯乙胺,如 美斯卡灵尽管如此,所有这些药物都通过α-肾上腺素能[5- 10] 羟色胺能]机制。直到最近,情况还不能这么说 苯环利定[PCP,天使尘]。然而,一个统一的能量-能量机制是 开始出现一种假设,即谷氨酸的释放可能代表了一种最终的共同点, 致幻剂的通道尽管如此,要说所有这些药物都以某种方式 在自然界中,多巴胺能受体掩盖了已知14种不同的多巴胺能受体的事实, 具有独特的神经解剖学分布和功能阵列。决定把重点放在 本文提出的关于5-HT_(2c)、5-HT_(7)、5-HT_(2_a)和5-HT_(2_a)~ d受体的建议,是基于对5-HT_(2_a)~(2_a)和5-HT_(2_a)~(2_a)受体的一些设想。 药理学和行为学证据,将这些受体与幻觉发生联系起来。的 主要的行为指标将继续是致幻剂对啮齿动物的刺激作用, 人们普遍认为,这些影响对人类具有显着的主观相关性。此外,本发明还提供了一种方法, 致幻剂将使用体内微透析来表征, 行为活动。预计综合所得数据将提供新的 了解迷幻剂的作用方式,尤其是那些容易被滥用的。在 此外,这些研究可能有助于我们了解最严重的精神疾病形式, 包括焦虑、抑郁和精神病在内的疾病。最后,互联网在 扩大对这些和其他俱乐部药物的兴趣,如MDMA [摇头丸],特别是在 社会青年阶层的吸毒率是不可估量的,但几乎肯定会导致非法吸毒的增加。 这种可能性加上对药物治疗用途的持续兴趣, 裸盖菇素对这些药物进行了详细的药理学评估,这是非常重要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JERROLD Clyne WINTER其他文献

JERROLD Clyne WINTER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JERROLD Clyne WINTER', 18)}}的其他基金

BEHAVIORAL & PHARMACOLOGICAL ANALYSIS OF DRUGS OF ABUSE
行为的
  • 批准号:
    3207876
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
Behavioral & Pharmacological Analysis of Drugs of Abuse
行为的
  • 批准号:
    6778352
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL AND PHARMACOLOGIC ANALYSIS OF DRUG OF ABUSE
滥用药物的行为和药理学分析
  • 批准号:
    2395832
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL & PHARMACOLOGICAL ANALYSIS OF DRUGS OF ABUSE
行为的
  • 批准号:
    3207879
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
Behavioral & Pharmacological Analysis of Drugs of Abuse
行为的
  • 批准号:
    6515364
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL & PHARMACOLOGICAL ANALYSIS OF DRUGS OF ABUSE
行为的
  • 批准号:
    2116740
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL AND PHARMACOLOGIC ANALYSIS OF DRUG OF ABUSE
滥用药物的行为和药理学分析
  • 批准号:
    2713059
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL & PHARMACOLOGICAL ANALYSIS OF DRUGS OF ABUSE
行为的
  • 批准号:
    3207873
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
BEHAVIORAL & PHARMACOLOGICAL ANALYSIS OF DRUGS OF ABUSE
行为的
  • 批准号:
    3207878
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:
Behavioral & Pharmacological Analysis of Drugs of Abuse
行为的
  • 批准号:
    6911502
  • 财政年份:
    1985
  • 资助金额:
    $ 28.76万
  • 项目类别:

相似海外基金

Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
  • 批准号:
    23H01982
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
  • 批准号:
    23KJ0116
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
  • 批准号:
    10682794
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
  • 批准号:
    10598276
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233343
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
  • 批准号:
    2233342
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
  • 批准号:
    479363
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
  • 批准号:
    10681989
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
  • 批准号:
    2237240
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
  • 批准号:
    2305592
  • 财政年份:
    2023
  • 资助金额:
    $ 28.76万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了